EIKN
Eikon Therapeutics, Inc.Company Information
- Company Name
- Eikon Therapeutics, Inc.
- CIK
- CIK0001861123
- Category
- <br>Emerging growth company
- Ticker: Exchange
- EIKN: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2836
- SIC Description
- Biological Products, (No Diagnostic Substances)
- Ticker
- EIKN
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-09-03
- Last sale
- —
- Shares purchased (TTM)
- 2,929,178
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 24,070,861
- Shares outstanding
- 54,143,162
- Ownership
- 44.46%
Earnings Market Reaction
- Filing date
- 2026-08-13
- Price on filing date
- —
- 1-month reaction
- 5.13%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||
| Cash And Cash Equivalents At Carrying Value | 143 | 161 | ||||||
| Marketable Securities Current | 389 | 351 | ||||||
| Prepaid Expense And Other Assets Current | 15 | 17 | ||||||
| Restricted Cash Current | 0 | 0 | ||||||
| Assets Current | 547 | 530 | ||||||
| Property Plant And Equipment Net | 133 | 138 | ||||||
| Operating Lease Right Of Use Asset | 91 | 91 | ||||||
| Marketable Securities Noncurrent | - | 84 | ||||||
| Restricted Cash Noncurrent | 8 | 8 | ||||||
| Other Assets Noncurrent | 1 | 1 | ||||||
| Assets | 780 | 851 | ||||||
Liabilities Current | ||||||||
| Accounts Payable Current | 7 | 6 | ||||||
| Accounts Payable And Other Accrued Liabilities Current | 39 | 29 | ||||||
| Operating Lease Liability Current | 9 | 10 | ||||||
| Liabilities Current | 55 | 45 | ||||||
| Operating Lease Liability Noncurrent | 243 | 245 | ||||||
| Other Liabilities Noncurrent | 15 | 10 | ||||||
| Liabilities | 313 | 300 | ||||||
| Redeemable Noncontrolling Interest Equity Preferred Carrying Amount | 0 | 0 | ||||||
Stockholders Equity | ||||||||
| Preferred Stock Value | 0 | 0 | ||||||
| Common Stock Value | 0 | 0 | ||||||
| Additional Paid In Capital Common Stock | 1,558 | 1,554 | ||||||
| Retained Earnings Accumulated Deficit | -1,092 | -1,003 | ||||||
| Stockholders Equity | 467 | 551 | ||||||
| Liabilities And Stockholders Equity | 780 | 851 | ||||||
| Temporary Equity Par Or Stated Value Per Share | 0.00 | 0.00 | ||||||
| Temporary Equity Shares Authorized | 0 | 0 | ||||||
| Temporary Equity Shares Issued | 0 | 0 | ||||||
| Temporary Equity Shares Outstanding | 0 | 0 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 50 | 50 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 500 | 500 | ||||||
| Common Stock Shares Issued | 54 | 54 | ||||||
| Shares Outstanding | 54 | 54 | ||||||
Select a line item above to chart it.
Recent filings
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialEikon Therapeutics, Inc. (EIKN) — SEC Financial Statements & Analysis
Eikon Therapeutics, Inc. (EIKN) is a biological products, (no diagnostic substances) company, incorporated in DE. Eikon Therapeutics, Inc. trades on Nasdaq as: EIKN. Eikon Therapeutics, Inc. (EIKN)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13. Based on that filing, Eikon Therapeutics, Inc. carries a market cap of $706.57M, a P/B ratio of 1.51x, and an enterprise value of $563.96M. On the balance sheet, it maintains a current ratio of 9.89x, a quick ratio of 9.61x, working capital of $491.68M, a debt-to-equity ratio of 0.67x, a debt ratio of 0.4, and net debt of $-142.61M. Figures sourced from SEC EDGAR.
- Market Cap
- $706.57M
- P/B TTM
- 1.51x
- Debt To Equity
- 0.67x
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Eikon Therapeutics, Inc. in?
Eikon Therapeutics, Inc. (EIKN) operates in the Biological Products, (No Diagnostic Substances) industry.
What exchange does EIKN trade on?
Eikon Therapeutics, Inc. (EIKN) trades on the Nasdaq.
Where is Eikon Therapeutics, Inc. incorporated?
Eikon Therapeutics, Inc. is incorporated in DE.
When was Eikon Therapeutics, Inc. (EIKN)'s most recent SEC filing?
Eikon Therapeutics, Inc. (EIKN)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13.
What is EIKN's market cap?
Eikon Therapeutics, Inc. (EIKN) has a market capitalization of $706.57M as of 2026-06-30.